Brentuximab (Anti-TNFRSF8 / CD30)Brentuximab (Anti-TNFRSF8 / CD30)
Move your mouse over image or click to enlarge

Brentuximab (Anti-TNFRSF8 / CD30)

Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.
Cat# Size Price Qty Buy
A2322-1mg*25 1mg*25
£3,415.00
A2322-1mg*5 1mg*5
£1,138.00
A2322-1mg 1mg
£384.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2322

Related Documents